MEDICINE OVERVIEW OF Glimfirst MV 1 mg Tablet (10 Tab)
THERAPEUTIC CLASS OF Glimfirst MV 1 mg Tablet (10 Tab)
WHY Glimfirst MV 1 mg Tablet (10 Tab) IS PRESCRIBED
Substitutes for - Glimfirst MV 1 mg Tablet (10 Tab)
HOW IT WORKS
HOW TO TAKE
WHEN TO TAKE
Glimfirst MV 1 mg Tablet (10 Tab) Warnings
Precautions of Glimfirst MV 1 mg Tablet (10 Tab)
Contraindications of Glimfirst MV 1 mg Tablet (10 Tab)
Side Effects of Glimfirst MV 1 mg Tablet (10 Tab)
Alcohol Interaction
Food to Avoid
Pregnancy/Lactation Protocol
Storage of Glimfirst MV 1 mg Tablet (10 Tab)
- Doctor's Note Required for this item
- Country of Origin: India
- 14 days Return Policy
- Manufacturer Details
Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg
About Glimfirst MV 1 mg Tablet:
Glimfirst MV 1 mg tablet is a combination of three antidiabetic medications, used to treat type 2 diabetes mellitus. It helps to control high blood glucose levels.
Each uncoated bilayered Glimfirst MV 1 mg tablet contains Metformin Hydrochloride 500 mg (In sustained release form), Glimepiride 1 mg, Voglibose 0.2 mg, and Excipients q.s.
Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.
Glimepiride, an antidiabeticsulphonylurea, reduces blood glucose by stimulating the insulin release from pancreatic ß-cells and decreases glucose output from the liver. It also increases insulin sensitivity at peripheral target sites.
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with type 2 diabetes mellitus.
Hence, the combination of Glimepiride, Metformin, and Voglibose complements each other and provides better glycemic control in the management of type 2 diabetes and probably in the prevention of its associated macrovascular and microvascular complications.
Use of Glimfirst MV 1 mg Tablet:
Glimfirst MV 1 mg tablet is prescribed for the treatment of patients with type 2 diabetes mellitus.
Usage direction of Glimfirst MV 1 mg Tablet:
- Glimfirst MV 1 mg tablet should be taken orally.
- Glimfirst MV 1 mg tablet is taken whole with the help of water.
- Do not crush, chew or break the tablet.
- Do not stop or skip the medicine without physician’s advice.
- Do not consume more than the prescribed quantity.
Precaution & Related information of Glimfirst MV 1 mg Tablet:
- If allergic to this medicine, inform the physician immediately.
- If find any other complication inform the physician immediately.
- Consult with the physician during pregnancy & lactation.
- Keep out of reach of children.
- It is dangerous to take this preparation except under medical supervision.
Storage direction of Glimfirst MV 1 mg Tablet:
Store protected from light and moisture, at a temperature not exceeding 30°C.
Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics and information, contained on or available through this website is for general information purposes only. SastaSundar.com makes no representation and assumes no responsibility for the accuracy of information contained on or available through this website and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources and review all information regarding any medical condition or treatment with your physician. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEBSITE.
SastaSundar.com does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, procedures, treatments, opinions or other information that may be contained on or available through this website.
